Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cardiac Dimensions closes its $35.5mm Series D

Executive Summary

Cardiac Dimensions (cardiovascular device) has raised $35.5mm through the closing of its Series D venture round. Johnson & Johnson Development Corp. co-led the financing with Lumira Capital. New investors Mitsubishi UFJ Capital, West River Capital, and Montgomery & Co. were joined by current backers Frazier Healthcare Ventures, InterWest Partners, MPM Capital, and Polaris Venture Partners. The company will use the proceeds for US and European trials of its Carillon Mitral Contour System to percutaneously treat functional mitral regurgitation. Montgomery & Co. was the placement agent.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies